CJC-1295 DAC 5mg / Ipamorelin 5mg Blend

Dual Research Peptide Blend for Growth Hormone Pathway, Recovery, Lean Muscle, Sleep, and Performance Research

What is CJC-1295 DAC 5mg / Ipamorelin 5mg?

CJC-1295 DAC 5mg / Ipamorelin 5mg is a research peptide blend containing two well-known compounds that are frequently studied together because they interact with different biological signaling pathways involved in growth hormone regulation. Rather than functioning as a single peptide, this blend combines two separate research compounds into one convenient lyophilized preparation for laboratory investigations. 0

CJC-1295 DAC is a modified growth hormone-releasing hormone (GHRH) analog that is investigated for its prolonged activity resulting from the Drug Affinity Complex (DAC) modification. Ipamorelin is a selective growth hormone secretagogue that interacts with the ghrelin (GHS-R1a) receptor pathway. Because these peptides act through different receptor systems, researchers often evaluate them together when studying growth hormone signaling, recovery physiology, lean muscle biology, metabolism, sleep-related pathways, and IGF-1 regulation. 1

The 5mg/5mg presentation provides equal amounts of both peptides, making it suitable for controlled laboratory investigations, comparative pathway analysis, and research focused on the interaction between GHRH receptor activity and ghrelin receptor signaling.

Learn more about the individual compounds:

Growth Hormone-Releasing Hormone (GHRH)

Research Overview

CJC-1295 DAC and Ipamorelin are frequently evaluated together because they stimulate different receptor pathways that influence growth hormone physiology. Research has focused on understanding how GHRH receptor activation and ghrelin receptor activation interact within endocrine systems to regulate hormone release, recovery mechanisms, metabolism, and cellular adaptation. 2

Experimental investigations involving this peptide blend commonly examine growth hormone pathway signaling, IGF-1 regulation, body composition models, skeletal muscle biology, connective tissue physiology, exercise recovery, protein synthesis, metabolic adaptation, sleep-related hormone activity, and healthy aging research.

Unlike studying either compound alone, combining CJC-1295 DAC with Ipamorelin allows researchers to evaluate how two complementary receptor systems may work together within controlled laboratory models. This has made the blend one of the most recognized combinations in growth hormone pathway research. 3

This product is supplied strictly for laboratory and analytical research. It is not intended for human use, veterinary use, diagnosis, or therapeutic applications.

Mechanism of Action & Research Pathways

CJC-1295 DAC is investigated for its interaction with growth hormone-releasing hormone receptors, while Ipamorelin is studied for its selective activation of the ghrelin (GHS-R1a) receptor. Since these peptides target different receptor systems, they provide researchers with an opportunity to investigate complementary signaling pathways involved in growth hormone regulation rather than competing for the same receptor. 4

Research involving this blend frequently examines growth hormone release patterns, IGF-1 production, protein synthesis, muscle recovery, connective tissue remodeling, metabolic regulation, sleep physiology, and endocrine feedback mechanisms. The complementary receptor activity has made this combination popular in laboratory models evaluating muscle biology, exercise recovery, healthy aging, and performance-related physiology. 5

CJC-1295 DAC 5mg / Ipamorelin 5mg Research Applications

• Growth hormone pathway research
• IGF-1 regulation studies
• Lean muscle physiology research
• Exercise recovery and performance models
• Protein synthesis investigations
• Sleep physiology and endocrine pathway research
• Healthy aging and longevity studies
• Body composition and metabolic pathway research
• Growth hormone receptor signaling investigations
• Comparative peptide and hormone signaling research

Why Are CJC-1295 DAC and Ipamorelin Studied Together?

Researchers frequently evaluate CJC-1295 DAC and Ipamorelin together because they activate different receptor systems involved in growth hormone regulation. CJC-1295 DAC primarily targets the growth hormone-releasing hormone (GHRH) receptor, while Ipamorelin selectively activates the ghrelin (GHS-R1a) receptor. These complementary mechanisms allow laboratories to investigate how dual-pathway stimulation influences growth hormone signaling, IGF-1 regulation, recovery physiology, and metabolic adaptation. 0

Because each peptide contributes through a different biological pathway, this blend is commonly used in laboratory models evaluating lean muscle biology, connective tissue physiology, exercise recovery, endocrine signaling, sleep-related hormone activity, and healthy aging research.

Why Choose Peptide Research Hub?

• High-quality research peptides
• Clearly labeled products with transparent specifications
• Third-party testing available for applicable products
• Fast order processing and dependable fulfillment
• Responsive customer support
• Research-focused product information to support laboratory investigations

View available analytical reports on our

Third-Party Testing

page.

Product Specifications

• Product: CJC-1295 DAC 5mg / Ipamorelin 5mg Blend
• Compound 1: CJC-1295 DAC
• Compound 2: Ipamorelin
• Quantity: 5mg / 5mg (10mg total)
• Form: Lyophilized powder
• Appearance: White to off-white powder
• Category: Research peptide blend
• Research Focus: Growth hormone signaling, IGF-1 regulation, recovery, lean muscle physiology, and endocrine pathway research
• Use: Laboratory research only

Storage & Handling

Store the lyophilized peptide blend according to standard laboratory procedures in a cool, dry environment away from excessive heat, moisture, and direct light. Proper storage helps preserve peptide integrity and consistency for research applications.

Frequently Asked Questions

What is CJC-1295 DAC 5mg / Ipamorelin 5mg?

A research peptide blend containing equal amounts of CJC-1295 DAC and Ipamorelin for laboratory investigations involving growth hormone signaling pathways.

Why are these peptides commonly studied together?

Researchers frequently investigate the combination because each peptide acts through a different receptor pathway involved in growth hormone regulation. 1

What research areas commonly use this blend?

Growth hormone signaling, IGF-1 regulation, lean muscle physiology, recovery research, metabolic studies, endocrine signaling, and healthy aging investigations.

Is this supplied as a lyophilized powder?

Yes. This product is supplied as a lyophilized research peptide blend.

Is this product intended for human use?

No. This product is intended strictly for laboratory research and analytical applications. It is not intended for human or veterinary use.

Related Research Peptides

• 
  Ipamorelin 5mg
  
• 
  CJC-1295 DAC 10mg
  
• 
  IGF-1 LR3 1mg
  
• 
  Sermorelin 10mg
  

Research Use Only: CJC-1295 DAC 5mg / Ipamorelin 5mg is intended strictly for laboratory research and analytical applications. Not for human or veterinary use.